PV

Priyal Vikramkumar Shah

Active Director Director DIN 01293653
DIN 01293653 First appointment Aug 2005 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Aug 2005
Shareholding value •••• Premium profile

About Priyal Vikramkumar Shah

Data last updated:

Priyal Vikramkumar Shah is a Director at Skyline Herbals Private Limited (since 2019), Whole-Time Director at Palmer Laboratories Private Limited (since 2005) and Designated Partner at Trans Surfactant Llp (since 2024). The companies operate in Healthcare, Pharma and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹42.33 Cr; the largest is Skyline Herbals Private Limited at ₹38.76 Cr (FY 2025). Earlier, Priyal Vikramkumar Shah was a Director at Lykis Herbals Private Limited (2015–2025) and Additional Director at Meso Carbon India Private Limited (2007–2011) and 1 more.

DIN 01293653
Primary Designation Director
Industry Healthcare
First Appointment 31 Aug 2005
Oldest Company Age 21 yrs
Largest company Skyline Herbals Private Limited · ₹38.76 Cr (FY 2025)
Combined revenue ₹42.33 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skyline Herbals Private Limited U24230GJ2019PTC109208
Director22 Jul 20192019₹38.76 Cr (FY 2025)Active
Palmer Laboratories Private Limited U24230GJ2005PTC046683
Whole-Time Director31 Aug 20052005₹3.58 Cr (FY 2025)Active
Designated Partner10 Nov 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lykis Herbals Private Limited U74140GJ2015PTC083567
Director17 Jun 20152015Active
Meso Carbon India Private Limited U24100GJ2007PTC051388
Additional Director03 Sep 20072007₹71.07 Cr (FY 2024)Active
Lykis Packaging Private Limited U74900MH2012PTC230784
Director09 May 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Palmer Laboratories Private Limited
Skyline Herbals Private Limited
Trans Surfactant Llp
Lykis Herbals Private Limited
Premium access

Shareholding and investment profile for Priyal Vikramkumar Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyal Vikramkumar Shah

Priyal Vikramkumar Shah currently holds 3 directorships: Skyline Herbals Private Limited (Director, since 22 Jul 2019, revenue ₹38.76 Cr (FY 2025)); Palmer Laboratories Private Limited (Whole-Time Director, since 31 Aug 2005, revenue ₹3.58 Cr (FY 2025)); Trans Surfactant Llp (Designated Partner, since 10 Nov 2024).

Priyal Vikramkumar Shah was first appointed on 31 Aug 2005 as Whole-Time Director at Palmer Laboratories Private Limited. The most recent appointment on record is 10 Nov 2024 at Trans Surfactant Llp.

The 2 current companies of Priyal Vikramkumar Shah that report revenue have a combined latest revenue of ₹42.33 Cr: Skyline Herbals Private Limited ₹38.76 Cr (FY 2025); Palmer Laboratories Private Limited ₹3.58 Cr (FY 2025).

Priyal Vikramkumar Shah held 3 earlier board appointments: Lykis Herbals Private Limited (Director, 17 Jun 2015 to 25 Jun 2025); Meso Carbon India Private Limited (Additional Director, 03 Sep 2007 to 17 Dec 2011); Lykis Packaging Private Limited (Director, 09 May 2012 to 06 Nov 2013).

The current boards of Priyal Vikramkumar Shah's companies include Rajeshkumar Chandan (Skyline Herbals Private Limited), Viresh Mehta Natwarlal (Skyline Herbals Private Limited), Vikrambhai Ambalal Vakil (Palmer Laboratories Private Limited), Dharmesh Dhirajlal Mehta (Trans Surfactant Llp), Hiteshkumar Dhirajlal Mehta (Trans Surfactant Llp), Ritesh Sancheti (Trans Surfactant Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available